EMulate/Hapbee Technology ReviewThe Bioteck Stock Review spent an entire week looking into their trials, studying management, and studying their advisory team – and this is the real deal folks. We won’t bore you with the details, that’s what the
report below is for. The report covers both EMulate and Hapbee and the stellar dream team assembled to move this mission forward.
The technology was developed to treat serious life-threatening medical ailments and has undergone human clinical trials for presenting data to the FDA.
Chris Rivera oversees the EMulate team of experts. He launched Hyperion Therapeutics in 2006 with $40 million. Publicly traded it was acquired for $1 billion in 2016.
On the team is Richard Henriques, former CFO of the Bill and Melinda Gates Foundation. Former Microsoft Chief Information Security (CISO) Officer Charles McNerney who is the current CISO for Expedia (EXPE). And Victor Levin, MD a world-renowned expert in brain tumor research known as the ‘Father of Neuro-Oncology’ and a dozen more high=profile individuals.
They have made numerous well-received presentations at prominent Medical Conferences including the Society for Neuro-Oncology.
They have demonstrated differential behavioral responses elicited in live animals.
The FDA granted it Humanitarian Use Designation designed to treat medulloblastoma, a rare, high-grade glioma in children.
https://internetstockreview.com/medical-technology-that-has-the-highest-potential-over-any-we-follow/
Client, see report for disclosure and disclaimer details.